Showing results (161-170 of 323) with videos related to
Sort By:
Pageof 33
Persoonia|March 5, 2015
Revision of agents of black-grain eumycetoma in the order PleosporalesS A Ahmed, W W J van de Sande, D A Stevens, et al.Journal of Surgical Oncology|June 23, 2022
Surgical management of 144 diffuse-type TGCT patients in a single institution: A 20-year cohort studyGeert Spierenburg, Lizz van der Heijden, Monique J L Mastboom, et al.Clinical Orthopaedics and Related Research|March 30, 2016
What Is the Role of Allogeneic Cortical Strut Grafts in the Treatment of Fibrous Dysplasia of the Proximal Femur?Bastiaan C J Majoor, Marleen J M Peeters-Boef, Michiel A J van de Sande, et al.Sarcoma|July 11, 2022
Malignant Transformation of Giant Cell Tumor of Bone and the Association with Denosumab Treatment: A Radiology and Pathology PerspectiveK van Langevelde, A H G Cleven, A Navas Cañete, et al.Scientific Reports|July 31, 2019
Easy-to-use clinical tool for survival estimation in Ewing sarcoma at diagnosis and after surgeryS E Bosma, C Lancia, A J Rueten-Budde, et al.Plos One|July 26, 2017
Addition of 17-(allylamino)-17-demethoxygeldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacyJeannine M Refos, Alieke G Vonk, Marian T Ten Kate, et al.International Orthopaedics|April 23, 2026
Long-term clinical outcomes of allograft-prosthetic reconstruction for tumours of the extremitiesPhilip T J Sanders, Sjors F van de Vusse, Giovanni Simonis, et al.Plos Neglected Tropical Diseases|April 27, 2018
Addressing the most neglected diseases through an open research model: The discovery of fenarimols as novel drug candidates for eumycetomaWilson Lim, Youri Melse, Mickey Konings, et al.Immunobiology|November 27, 2009
Aspergillus fumigatus conidial melanin modulates host cytokine responseLouis Y A Chai, Mihai G Netea, Janyce Sugui, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 2, 2021
Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational studyMaartje E Meier, Stance N Clerkx, Elizabeth M Winter, et al.Pageof 33